M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 3.55 USD 0.28% Market Closed
Market Cap: 373.8m USD
Have any thoughts about
MaxCyte Inc?
Write Note

MaxCyte Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MaxCyte Inc
Cost of Revenue Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
M
MaxCyte Inc
NASDAQ:MXCT
Cost of Revenue
-$4.7m
CAGR 3-Years
-20%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cost of Revenue
-$25B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-11%
Danaher Corp
NYSE:DHR
Cost of Revenue
-$8.6B
CAGR 3-Years
8%
CAGR 5-Years
-4%
CAGR 10-Years
0%
Mettler-Toledo International Inc
NYSE:MTD
Cost of Revenue
-$1.5B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-3%
Agilent Technologies Inc
NYSE:A
Cost of Revenue
-$2.9B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
-11%
IQVIA Holdings Inc
NYSE:IQV
Cost of Revenue
-$9.9B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-10%

See Also

What is MaxCyte Inc's Cost of Revenue?
Cost of Revenue
-4.7m USD

Based on the financial report for Dec 31, 2023, MaxCyte Inc's Cost of Revenue amounts to -4.7m USD.

What is MaxCyte Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-21%

Over the last year, the Cost of Revenue growth was 7%. The average annual Cost of Revenue growth rates for MaxCyte Inc have been -20% over the past three years , -21% over the past five years .

Back to Top